Stay updated on Daratumumab in Waldenström Macroglobulinemia Clinical Trial

Sign up to get notified when there's something new on the Daratumumab in Waldenström Macroglobulinemia Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab in Waldenström Macroglobulinemia Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The ClinicalTrials.gov page’s site revision changes from v3.8.0 to v3.8.1.
    Difference
    0.1%
    Check dated 2026-11-21T12:18:23.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The clinical-trial record for Daratumumab in relapsed or refractory Waldenström macroglobulinemia is displayed with its study details, participant criteria, outcomes, locations, and record documents.
    Difference
    50%
    Check dated 2026-11-07T11:51:14.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The site revision identifier updates from v3.7.2 to v3.8.0. The page continues to show a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-31T12:34:11.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    A banner was added announcing NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology and linking to related updates and FAQs.
    Difference
    1%
    Check dated 2026-10-24T12:12:51.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.1 to v3.7.2. The study page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-17T13:10:05.000Z thumbnail image
  7. Check
    43 days ago
    Change Detected
    Summary
    The page remains an access-denied error, with the site revision changing from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-10T13:57:13.000Z thumbnail image

Stay in the know with updates to Daratumumab in Waldenström Macroglobulinemia Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab in Waldenström Macroglobulinemia Clinical Trial page.